LL-37

LL-37 is the only cathelicidin antimicrobial peptide naturally produced in humans, generated by immune cells and epithelial tissue as part of the innate immune response. Beyond its antimicrobial properties, LL-37 is studied for its immunomodulatory role, including interactions with formyl peptide receptors on immune cells. These receptor interactions are thought to influence the recruitment and activity of immune cells at sites of chronic inflammation, positioning LL-37 as a peptide of interest for supporting balanced inflammatory signaling. EdgeRx offers LL-37 through a clinician-supervised protocol, prescribed by licensed physicians for eligible patients as part of an individualized recovery and immune support plan.